Impact of diabetes mellitus on old patients undergoing coronary artery bypass grafting
Related Experiment Video
Updated: Jun 18, 2026

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
Published on: March 7, 2025
Qiang Ji1, Yunqing Mei, Xisheng Wang
1Department of Thoracic Cardiovascular Surgery, Tongji Hospital, Tongji University, Shanghai, P.R. China.
Insights
Elderly patients with diabetes undergoing coronary artery bypass grafting (CABG) face similar mortality and morbidity rates as nondiabetics. The primary increased risk for diabetics is deep sternal wound infection, suggesting good outcomes are achievable.
Area of Science:
- Cardiovascular Surgery
- Diabetology
- Geriatric Medicine
Background:
- Coronary artery bypass grafting (CABG) is a common procedure for cardiovascular disease.
- Outcomes in elderly diabetic patients undergoing CABG require further investigation.
- Diabetes is a significant comorbidity impacting surgical results.
Purpose of the Study:
- To compare outcomes of elderly diabetic versus nondiabetic patients after isolated CABG.
- To identify specific risks and benefits for diabetic patients undergoing CABG.
- To evaluate the impact of diabetes on postoperative complications and mortality.
Main Methods:
- Retrospective analysis of pre-, intra-, and postoperative data.
- Inclusion of all CABG patients over 65 years of age from January 2004 to December 2008.
- Definition of diabetes based on medication requirements (oral or insulin).
Main Results:
- Diabetic patients (over 65) were less likely to have had prior percutaneous coronary intervention (PCI) and more likely to undergo cardiopulmonary bypass (CPB).
- Elderly diabetic patients showed a significantly higher rate of deep sternal wound infection (OR = 2.76).
- Other morbidities and mortality rates were comparable between elderly diabetic and nondiabetic patients.
Conclusions:
- Elderly diabetic patients undergoing isolated CABG experience comparable overall outcomes to their nondiabetic counterparts.
- Deep sternal wound infection is a key complication to monitor in this population.
- Excellent results following CABG can be anticipated for elderly diabetic patients.
Abstract:
Few reports have focused on whether old diabetic patients had worse outcomes compared to old nondiabetics after coronary artery bypass grafting (CABG). This study aimed to evaluate the outcomes of old diabetic patients compared to old nondiabetics following isolated CABG. From January 2004 to December 2008, the relevant pre-, intra-, and postoperative materials of all CABG patients over 65 years of age in our center were investigated and analyzed retrospectively. In this study, diabetes is defined as the need for oral medication or insulin. A total of 140 diabetic patients over 65 years of age were entered in the study, accounting for 31.7% of the total population. Diabetic patients over 65 years of age were less likely to have undergone previous percutaneous coronary intervention (P < 0.0001) and more likely to undergo CPB (P = 0.03) during CABG as compared to nondiabetics over 65 years of age. Univariate analysis and multivariate logistic regression analysis showed diabetic patients over 65 years of age only had a higher rate of deep sternal wound infection (OR = 2.76, 95%CI 1.22-7.83, P = 0.002), while sharing almost similar rates among other morbidities and mortality as compared to nondiabetic patients over 65 years of age. Excellent results following CABG may be expected in old diabetic patients.
Related Concept Videos
Complications of Diabetes Mellitus
Peripheral Artery Disease V: Postoperative Nursing Management
Diabetes Mellitus: Type 2 and Gestational
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Diabetic Neuropathy
Type I Diabetes II: Pathophysiology